Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

导出原文传递

翻译打印收藏纠错

作者： Elf, Shannon ^[1] ; Abdelfattah, Nouran S. ^[2] ; Chen, Edwin ^[3] ; Perales-Paton, Javier ^[4] ; Rosen, Emily A. ; Ko, Amy ; Peisker, Fabian ; Florescu, Natalie ; Giannini, Silvia ; Wolach, Ofir ; Morgan, Elizabeth A. ; Tothova, Zuzana ; Losman, Julie-Aurore ; Schneider, Rebekka K. ; Al-Shahrour, Fatima ; Mullally, Ann

作者单位： Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA ^[1] Spanish Natl Canc Res Ctr CNIO, Clin Res Programme, Translat Bioinformat Unit, Madrid, Spain ^[2] Broad Inst, Cambridge, MA USA ^[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA ^[4]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer discovery.

2016年6卷4期

368-381页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

Cancer discovery.

相似文献

Cancer discovery.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

Cancer discovery.

相似文献

Cancer discovery.

相关期刊

检索历史清除